These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 26430173)
1. Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion. Elayeb R; Tamagne M; Bierling P; Noizat-Pirenne F; Vingert B Haematologica; 2016 Feb; 101(2):209-18. PubMed ID: 26430173 [TBL] [Abstract][Full Text] [Related]
2. The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Hendrickson JE; Saakadze N; Cadwell CM; Upton JW; Mocarski ES; Hillyer CD; Zimring JC Transfusion; 2009 Aug; 49(8):1678-84. PubMed ID: 19413728 [TBL] [Abstract][Full Text] [Related]
3. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580 [TBL] [Abstract][Full Text] [Related]
4. Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Hendrickson JE; Roback JD; Hillyer CD; Easley KA; Zimring JC Transfusion; 2008 Sep; 48(9):1869-77. PubMed ID: 18564394 [TBL] [Abstract][Full Text] [Related]
5. Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice. Escamilla-Rivera V; Liu J; Gibb DR; Santhanakrishnan M; Liu D; Forsmo JE; Eisenbarth SC; Foxman EF; Stowell SR; Luckey CJ; Zimring JC; Hudson KE; Hendrickson JE Blood; 2020 May; 135(22):1983-1993. PubMed ID: 32266378 [TBL] [Abstract][Full Text] [Related]
6. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector. Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563 [TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Wu J; Meng Z; Jiang M; Zhang E; Trippler M; Broering R; Bucchi A; Krux F; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF Immunology; 2010 Mar; 129(3):363-74. PubMed ID: 19922426 [TBL] [Abstract][Full Text] [Related]
9. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627 [TBL] [Abstract][Full Text] [Related]
10. Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells. Kroeger DR; Rudulier CD; Bretscher PA PLoS One; 2013; 8(10):e77346. PubMed ID: 24155947 [TBL] [Abstract][Full Text] [Related]
11. The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs. Richards AL; Sheldon K; Wu X; Gruber DR; Hudson KE Front Immunol; 2018; 9():2200. PubMed ID: 30344520 [No Abstract] [Full Text] [Related]
12. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410 [TBL] [Abstract][Full Text] [Related]
13. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity. Quah B; Ni K; O'Neill HC Int Immunol; 2004 Apr; 16(4):567-77. PubMed ID: 15039387 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients. Vingert B; Tamagne M; Habibi A; Pakdaman S; Ripa J; Elayeb R; Galacteros F; Bierling P; Ansart-Pirenne H; Bartolucci P; Noizat-Pirenne F Eur J Immunol; 2015 Jun; 45(6):1868-79. PubMed ID: 25763868 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands. Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904 [TBL] [Abstract][Full Text] [Related]
16. The role of the e3 ligase cbl-B in murine dendritic cells. Wallner S; Lutz-Nicoladoni C; Tripp CH; Gastl G; Baier G; Penninger JM; Stoitzner P; Wolf D PLoS One; 2013; 8(6):e65178. PubMed ID: 23762309 [TBL] [Abstract][Full Text] [Related]
19. The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice. Salem ML; Diaz-Montero CM; El-Naggar SA; Chen Y; Moussa O; Cole DJ Vaccine; 2009 Jan; 27(4):549-57. PubMed ID: 19027047 [TBL] [Abstract][Full Text] [Related]
20. In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Scarlett UK; Cubillos-Ruiz JR; Nesbeth YC; Martinez DG; Engle X; Gewirtz AT; Ahonen CL; Conejo-Garcia JR Cancer Res; 2009 Sep; 69(18):7329-37. PubMed ID: 19738057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]